The human history has witnessed the rapid development of technologies such as high-
throughput sequencing and mass spectrometry that led to the concept of 'omics' and …

Endometrial cancer (EC), a prevalent gynecological malignancy, presents significant
challenges due to its genetic complexity and heterogeneity. The genomic landscape of EC is …

Analyzed endometrial cancer (EC) genomes have allowed for the identification of molecular
signatures, which enable the classification, and sometimes prognostication, of these …

HER2 status is now routinely assessed in endometrial serous carcinoma (ESC) due to the
reported predictive value of HER2 protein overexpression and/or gene amplification. Herein …

Purpose Endometrial cancer is the most common gynecological malignancy. The helicase
RIG-I, a part of the innate immune system, and EFTUD2, a splicing factor which can …

[4, 5]. Finally, tumors with NSMP—in essence, those tumors who do not fall into any of the
other 3 groups—tend to have endometrioid histology and are frequently estrogen …

Whether immunohistochemistry (IHC) of p53 accurately reflects the TP53 mutational status
of endometrial carcinoma (EC) has not yet been established. This study aimed to clarify the …

Introduction Among uterine malignancies, endometrial cancer (EC) is the most common
cancer of the female reproductive tract. Traditionally, risk stratification in EC is determined by …

Advances in the global personalized medicine market are directly related to innovations and
developments in molecular and genetic technologies. This review focuses on the key trends …

Background Gynecological cancers are the most lethal malignancies among females, most
of which are associated with gene mutations. Few studies have compared the differences in …